Diarrhea News and Research

Latest Diarrhea News and Research

Preclinical data suggest CuraGen's Velafermin may protect the gastrointestinal tract and decrease associated toxicity following exposure to radiation

New preclinical data on velafermin (CG53135), CuraGen's Phase II clinical product being developed for the prevention of oral mucositis (OM), suggesting that velafermin may protect the gastrointestinal tract and decrease associated toxicity, including enteritis and diarrhea, following exposure to radiation.

1 Jul 2005

$5.1 billion could save 6 million children

Six million children could be saved if $5.1 billion in new resources for preventive and therapeutic interventions were provided each year, according to researchers from the Johns Hopkins Bloomberg School of Public Health and other institutions.

27 Jun 2005

Found! - mutant viruses that laid NSW low with gastro

New mutant viruses responsible for gastroenteritis outbreaks in New South Wales in recent times have been identified by research published in Emerging Infectious Diseases, a journal of the US Centers for Disease Control.

27 Jun 2005

3 health workers arrested after hepatitis vaccine kills a schoolchild and makes 120 others ill

After a hepatitis vaccine was administered in their schools in central China, one child died and another 120 have become ill.

27 Jun 2005

FDA approves treatment for diarrhea caused by Cryptosporidium infection

The U.S. Food and Drug Administration (FDA) has approved Alinia (nitazoxanide) tablets and oral suspension for treating diarrhea caused by Cryptosporidium parvum infection in adults and children 12 years and older. The product, already approved to treat the same infection in younger children, received a priority review by FDA.

19 Jun 2005

Cholera epidemic feared in Afghan capital

More than 2,000 cases of cholera have been reported in the Afghan capital Kabul, and health experts fear the city is on the verge of a cholera epidemic.

14 Jun 2005

Rimonabant study shows significant improvements in HbA1c and cardiometabolic risk factors in people with type 2 diabetes

The reported results of a one-year phase III study in 1045 people with type 2 diabetes treated with rimonabant, the first in a new class of therapeutic agents called selective CB1 Blockers, were that rimonabant 20 mg significantly improved HbA1c (a measure of blood sugar control), dyslipidemia (abnormal levels of fat in the blood), and systolic blood pressure with a concomitant substantial reduction in abdominal obesity in people with type 2 diabetes treated with oral anti-diabetic medications and requiring further control.

12 Jun 2005

European approval of Temodal (temozolomide) capsules for treatment of glioblastoma multiforme

Schering-Plough announced today that the European Commission has granted approval of Temodal (temozolomide) Capsules for first-line use for the treatment of patients with newly diagnosed glioblastoma multiforme (GBM), the most common and aggressive form of primary brain cancer.

10 Jun 2005

Researchers discover how hepatic-C virus evades immune system in acute and chronic infections

Researchers at Johns Hopkins have uncovered how a majority of the genetic changes in the hepatic-C virus, the most common cause of liver disease, allow it to evade the body's immune system during infection.

10 Jun 2005

Information to guide child health policy is lacking in the poorest countries with the highest rates of childhood mortality

Around 10.8 million children die worldwide each year. Credible global and national estimates of the burden of disease in childhood are essential for the development of appropriate health policy and implementation of health interventions to prevent these deaths.

9 Jun 2005

Drinking cranberry juice may fight that tummy bug

A new study suggests that cranberry juice, a well documented remedy to help prevent urinary tract infections, may also work against gastrointestinal viruses.

8 Jun 2005

Superbug possibly the same as US killer strain

Microbiologists at the Health Protection Agency suspect that the superbug which has already caused 12 deaths at Stoke Mandeville Hospital, in Buckinghamshire, may be the same strain that has spread in many American hospitals since 2001, and killed more than 100 patients in Quebec, Canada, last year.

8 Jun 2005

12 deaths creates new infection scare in UK hospitals

There have been some 300 cases of Clostridium difficile in 18 months at Stoke Mandeville Hospital, in Aylesbury, Bucks, a national centre for spinal injury, and it is thought that the infection was an "actual or probable" factor in 12 deaths in that time.

6 Jun 2005

New process removes allergy potential from peanut products

Scientists say a special fermentation process may significantly reduce the potential for allergic reaction to peanut products.

6 Jun 2005

Basic sanitation must reach 138 million more people every year through 2015

...close to 2 billion in total - to bring the world on track to halve the proportion of people living without safe water and basic sanitation, the World Health Organization (WHO) and UNICEF warn in a new report.

6 Jun 2005

Lactose intolerance linked to ancestral environment

Got milk? Many people couldn't care less because they can't digest it. A new Cornell University study finds that it is primarily people whose ancestors came from places where dairy herds could be raised safely and economically, such as in Europe, who have developed the ability to digest milk.

1 Jun 2005

Stimulating innate immunity helps ease Crohn's disease symptoms

Like throwing oil on a fire or prescribing a high cholesterol diet for heart patients, gastroenterologists traditionally have believed that it would not be a good idea to stoke up the body's immune system to treat Crohn's disease.

26 May 2005

FDA recommends approval of the investigational anti-HIV drug tipranavir

Boehringer Ingelheim today announced that the U.S. Food and Drug Administration's (FDA) Antiviral Drugs Advisory Committee recommended the approval of the investigational anti-HIV drug tipranavir (11-3). Tipranavir is a non-peptidic protease inhibitor that requires boosting with low-dose ritonavir and must be used in combination with other antiretroviral agents.

20 May 2005

Integrated approach to child survival achieving important results

An integrated approach to child survival designed to deliver a package of lifesaving health services for children in hard to reach communities has shown remarkable results, UNICEF Executive Director Ann M. Veneman announced at the World Health Assembly.

18 May 2005

Gluten exposure at 4 to 6 months of age lowers risk of celiac disease

Children with gluten exposure from cereal grains at 4 to 6 months of age have a lower risk of celiac disease than children with exposure before or after this time period, according to a study in the May 18 issue of JAMA.

17 May 2005

Diarrhea News and Research

Latest Diarrhea News and Research

Preclinical data suggest CuraGen's Velafermin may protect the gastrointestinal tract and decrease associated toxicity following exposure to radiation

$5.1 billion could save 6 million children

Found! - mutant viruses that laid NSW low with gastro

3 health workers arrested after hepatitis vaccine kills a schoolchild and makes 120 others ill

FDA approves treatment for diarrhea caused by Cryptosporidium infection

Cholera epidemic feared in Afghan capital

Rimonabant study shows significant improvements in HbA1c and cardiometabolic risk factors in people with type 2 diabetes

European approval of Temodal (temozolomide) capsules for treatment of glioblastoma multiforme

Researchers discover how hepatic-C virus evades immune system in acute and chronic infections

Information to guide child health policy is lacking in the poorest countries with the highest rates of childhood mortality

Drinking cranberry juice may fight that tummy bug

Superbug possibly the same as US killer strain

12 deaths creates new infection scare in UK hospitals

New process removes allergy potential from peanut products

Basic sanitation must reach 138 million more people every year through 2015

Lactose intolerance linked to ancestral environment

Stimulating innate immunity helps ease Crohn's disease symptoms

FDA recommends approval of the investigational anti-HIV drug tipranavir

Integrated approach to child survival achieving important results

Gluten exposure at 4 to 6 months of age lowers risk of celiac disease

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Diarrhea News and Research

Latest Diarrhea News and Research

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in